alexa
Reach Us +44-7460312890
Mori J. Krantz | OMICS International
ISSN: 2329-9517

Journal of Cardiovascular Diseases & Diagnosis
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Mori J. Krantz

 Denver Health Medical Center, USA

Biography


 Mori did his undergraduate training at  Emory University and graduated from Temple University School of Medicine. He is board-certified in internal medicine and cardiovascular medicine and is a fellow of the American College of Cardiology. He completed residency and fellowship training at the University of Colorado. Dr. Krantz also currently directs the cardiac risk reduction program at Denver Health and Hospital Authority and is an Associate Professor of Medicine, at the University of Colorado.He is committed to improving cardiac safety in new drug development as a Member of the US FDA Cardiovascular and Renal Drugs Advisory Committee.  Within the field of drug-induced arrhythmia, he serves on a US Department of Health and Human Services Expert Panel on cardiac safety.  Mori’s commitment to safety and quality of care is further exemplified by his service on an AHA national steering committee, Get With The Guidelines, the largest inpatient quality improvement program in the US that has successfully improved care for coronary artery disease, stroke, and heart failure patients.  Dr. Krantz is an author or co-author of nearly 100 scholarly publications pertaining to the prevention and treatment of cardiovascular diseases

Research Interest

Cardiovascular risk reduction

Cardiac safety in new drug development

Improved care for coronary artery disease,stroke and heart failure patients

Publications

Global Speakers in the subject

Global Experts in the subject

Top